Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01189 (
beta-endorphin
)
21,003
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The pituitary hormones
adrenocorticotropic hormone (ACTH)
,
beta-endorphin
, and alpha-melanocyte stimulating hormone (alpha-MSH) are synthesized by proteolytic processing of their common proopiomelanocortin (POMC) precursor. Key findings from this study show that
cathepsin L
functions as a major proteolytic enzyme for the production of POMC-derived peptide hormones in secretory vesicles. Specifically,
cathepsin L
knock-out mice showed major decreases in ACTH,
beta-endorphin
, and alpha-MSH that were reduced to 23, 18, and 7% of wild-type controls (100%) in pituitary. These decreased peptide levels were accompanied by increased levels of POMC consistent with proteolysis of POMC by
cathepsin L
. Immunofluorescence microscopy showed colocalization of
cathepsin L
with
beta-endorphin
and alpha-MSH in the intermediate pituitary and with ACTH in the anterior pituitary. In contrast,
cathepsin L
was only partially colocalized with the lysosomal marker Lamp-1 in pituitary, consistent with its extralysosomal function in secretory vesicles. Expression of
cathepsin L
in pituitary AtT-20 cells resulted in increased ACTH and
beta-endorphin
in the regulated secretory pathway. Furthermore, treatment of AtT-20 cells with CLIK-148, a specific inhibitor of
cathepsin L
, resulted in reduced production of ACTH and accumulation of POMC. These findings demonstrate a prominent role for
cathepsin L
in the production of ACTH,
beta-endorphin
, and alpha-MSH peptide hormones in the regulated secretory pathway.
...
PMID:Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrated by protease gene knockout and expression. 1884 46
The production of the peptide hormones ACTH,
alpha-MSH
, and
beta-endorphin
requires proteolytic processing of POMC which is hypothesized to utilize dual cysteine- and subtilisin-like protease pathways, consisting of the secretory vesicle
cathepsin L
pathway and the well-known subtilisin-like prohormone convertase (PC) pathway. To gain knowledge of these protease components in human pituitary where POMC-derived peptide hormones are produced, this study investigated the presence of these protease pathway components in human pituitary. With respect to the
cathepsin L
pathway, human pituitary contained
cathepsin L
of 27-29 kDa and aminopeptidase B of approximately 64 kDa, similar to those in secretory vesicles of related neuroendocrine tissues. The serpin inhibitor endopin 2, a selective inhibitor of
cathepsin L
, was also present. With respect to the PC pathway, human pituitary expresses PC1/3 and PC2 of approximately 60-65 kDa, which represent active PC1/3 and PC2; peptide hormone production then utilizes carboxypeptidase E (CPE) which is present as a protein of approximately 55 kDa. Analyses of POMC products in human pituitary showed that they resemble those in mouse pituitary which utilizes
cathepsin L
and PC2 for POMC processing. These findings suggest that human pituitary may utilize the
cathepsin L
and prohormone convertase pathways for producing POMC-derived peptide hormones.
...
PMID:Human pituitary contains dual cathepsin L and prohormone convertase processing pathway components involved in converting POMC into the peptide hormones ACTH, alpha-MSH, and beta-endorphin. 1934 78